Showing results (581-590 of 823) with videos related to

Sort By:
Pageof 83
Lupus|May 3, 2014
Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosusM Jolly, S Francis, R Aggarwal, et al.
Annals of Internal Medicine|November 1, 1981
Hormonal and metabolic effects of a pancreatic endocrine graft. Vascularized segmental transplantation in insulin-dependent diabetic patientsD E Sutherland, J S Najarian, B Z Greenberg, et al.
Environmental Microbiology Reports|February 7, 2026
Nutritional and Microbial Responses of Pocillopora verrucosa to Co-Culture With Chromis viridis DamselfishRachel C Neil, Jonathan A Barton, Andrew Heyward, et al.
Brain : a Journal of Neurology|August 26, 1998
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy studyN De Stefano, P M Matthews, L Fu, et al.
Minerva Medica|June 16, 2015
FlexiQule (Boswellia extract) in the supplementary management of osteoarthritis: a supplement registryG Belcaro, M Dugall, R Luzzi, et al.
Talanta|July 1, 2008
A screening test for heroin based on sequential injection analysis with dual-reagent chemiluminescence detectionLauren A Hill, Claire E Lenehan, Paul S Francis, et al.
The Biochemical Journal|February 11, 2010
Electrostatic interactions play a minor role in the binding of ExoS to 14-3-3 proteinsLubna Yasmin, Jeffrey L Veesenmeyer, Maureen H Diaz, et al.
Science Translational Medicine|May 20, 2011
Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejectionGang Feng, Satish N Nadig, Liselotte Bäckdahl, et al.
Analytical and Bioanalytical Chemistry|December 10, 2013
Determination of neurotransmitters and their metabolites using one- and two-dimensional liquid chromatography with acidic potassium permanganate chemiluminescence detectionBrendan J Holland, Xavier A Conlan, Paul G Stevenson, et al.
American Heart Journal|December 19, 2006
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudyW H Wilson Tang, Steven R Steinhubl, Frederick Van Lente, et al.
Pageof 83